For example, ZNF746, a new parkin/interacting substrate also known as PARIS, leads to progressive loss of dopamine and DA neurons in the substantia nigra, a specific hallmark of Parkinson’s disease [91]. This evidence concerns the gene ZNF746 and Parkinson disease.